Impact of exosome therapy on pancreatic cancer and its progression

[1]  Liangqing Yao,et al.  Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer , 2023, Cancer control : journal of the Moffitt Cancer Center.

[2]  Chuan Wang,et al.  The Roles of Exosomal Proteins: Classification, Function, and Applications , 2023, International journal of molecular sciences.

[3]  A. Gasbarrini,et al.  Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives , 2023, International journal of molecular sciences.

[4]  J. V. Van Ginderachter,et al.  Hallmarks of Cancer Affected by the MIF Cytokine Family , 2023, Cancers.

[5]  M. Taheri,et al.  Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy , 2022, Cancer Cell International.

[6]  Yinmo Yang,et al.  Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1 , 2022, Chinese medical journal.

[7]  Yi Liu,et al.  Natural products exert anti-tumor effects by regulating exosomal ncRNA , 2022, Frontiers in Oncology.

[8]  Y. Mou,et al.  Functions and clinical applications of exosomes in pancreatic cancer , 2022, Molecular Biology Reports.

[9]  S. Che,et al.  CD47 as a promising therapeutic target in oncology , 2022, Frontiers in Immunology.

[10]  V. I. Evtushenko,et al.  Principles and Problems of Exosome Isolation from Biological Fluids , 2022, Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology.

[11]  Chulhee Choi,et al.  Manufacturing Therapeutic Exosomes: from Bench to Industry , 2022, Molecules and cells.

[12]  W. Vermeij,et al.  Chemotherapy Side-Effects: Not All DNA Damage Is Equal , 2022, Cancers.

[13]  L. Du,et al.  Review on Strategies and Technologies for Exosome Isolation and Purification , 2022, Frontiers in Bioengineering and Biotechnology.

[14]  Nahid Arghiani,et al.  Modulating microRNAs in cancer: next-generation therapies , 2021, Cancer biology & medicine.

[15]  Yong Li,et al.  The Emerging Role of Exosomes in Cancer Chemoresistance , 2021, Frontiers in Cell and Developmental Biology.

[16]  Xiaojun Lin,et al.  Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection , 2021, Journal of oncology.

[17]  Himansu Sekhar Nanda,et al.  Exosomes, a New Star for Targeted Delivery , 2021, Frontiers in Cell and Developmental Biology.

[18]  B. Daniele,et al.  Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting , 2021, Frontiers in Oncology.

[19]  M. Korc,et al.  The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy , 2021, Frontiers in Oncology.

[20]  V. James,et al.  The Role of Extracellular Vesicles in the Development of a Cancer Stem Cell Microenvironment Niche and Potential Therapeutic Targets: A Systematic Review , 2021, Cancers.

[21]  J. Yi,et al.  The biology, function, and applications of exosomes in cancer , 2021, Acta pharmaceutica Sinica. B.

[22]  Kefeng Wang,et al.  CircRNA ciRS-7: a Novel Oncogene in Multiple Cancers , 2021, International journal of biological sciences.

[23]  P. Bossuyt,et al.  Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. , 2020, JAMA oncology.

[24]  K. Al‐Jamal,et al.  Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment. , 2020, Biomaterials.

[25]  Y. Tao,et al.  Exosomes: key players in cancer and potential therapeutic strategy , 2020, Signal Transduction and Targeted Therapy.

[26]  George A Calin,et al.  MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods , 2020, Cancers.

[27]  Lei Gao,et al.  Exosomal miR‐21/Let‐7a ratio distinguishes non‐small cell lung cancer from benign pulmonary diseases , 2020, Asia-Pacific journal of clinical oncology.

[28]  M. Reese,et al.  Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma , 2020, Cancers.

[29]  Chengping Hu,et al.  Role of exosomal microRNAs in lung cancer biology and clinical applications , 2020, Cell proliferation.

[30]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[31]  M. Reese,et al.  Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma , 2020, Cancers.

[32]  Muhammad Jamal,et al.  Recent Progress on Circular RNA Research in Acute Myeloid Leukemia , 2019, Front. Oncol..

[33]  Fangfang Zhou,et al.  Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy , 2019, Advanced science.

[34]  Wenyuan Zhao,et al.  Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance , 2019, Journal of Cancer.

[35]  Wei Li,et al.  Tumour-Secreted Hsp90α on External Surface of Exosomes Mediates Tumour - Stromal Cell Communication via Autocrine and Paracrine Mechanisms , 2019, Scientific Reports.

[36]  Yuntao Shi,et al.  Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer , 2019, International Journal of Clinical Oncology.

[37]  C. Pilarsky,et al.  The Role of Exosomes in Pancreatic Cancer , 2019, International journal of molecular sciences.

[38]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[39]  Samuel A. Wickline,et al.  Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles , 2019, Oncotarget.

[40]  F. Guan,et al.  Tumor-Derived Exosomes Mediate the Instability of Cadherins and Promote Tumor Progression , 2019, International journal of molecular sciences.

[41]  A. Correa,et al.  Metastatic Niches and the Modulatory Contribution of Mesenchymal Stem Cells and Its Exosomes , 2019, International journal of molecular sciences.

[42]  Dihua Yu,et al.  Exosomes in cancer development, metastasis, and immunity. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[43]  W. Yuan,et al.  Effects of exosomes on pre-metastatic niche formation in tumors , 2019, Molecular Cancer.

[44]  S. Melo,et al.  Exosomes and the Future of Immunotherapy in Pancreatic Cancer , 2019, International journal of molecular sciences.

[45]  Alain Viari,et al.  The circular RNome of primary breast cancer , 2019, Genome research.

[46]  M. Akhtar,et al.  Paget’s “Seed and Soil” Theory of Cancer Metastasis: An Idea Whose Time has Come , 2019, Advances in anatomic pathology.

[47]  T. Abraham,et al.  Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages , 2018, PloS one.

[48]  I. Weissman,et al.  CD47 Blockade by Hu5F9‐G4 and Rituximab in Non‐Hodgkin's Lymphoma , 2018, The New England journal of medicine.

[49]  G. Meister,et al.  Regulation of microRNA biogenesis and its crosstalk with other cellular pathways , 2018, Nature Reviews Molecular Cell Biology.

[50]  G. Baldwin,et al.  p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation , 2018, World journal of gastroenterology.

[51]  Xiaowu Li,et al.  Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis , 2018, Journal of experimental & clinical cancer research : CR.

[52]  T. Shlomi,et al.  Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma. , 2018, Cancer research.

[53]  Wei Zhang,et al.  Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response , 2018, Nature.

[54]  K. Richards,et al.  Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy , 2018, Front. Oncol..

[55]  Hui Liu,et al.  Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma , 2018, Oncogene.

[56]  G. Kenter,et al.  Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review , 2018, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[57]  Y. Li,et al.  Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein , 2018, Annals of the rheumatic diseases.

[58]  Lianfang Zheng,et al.  Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications , 2018, Molecular Cancer.

[59]  S. Melo,et al.  The Biology of Cancer Exosomes: Insights and New Perspectives. , 2017, Cancer research.

[60]  J. Neuzil,et al.  Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression , 2017, Scientific Reports.

[61]  G. Basso,et al.  PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis , 2017, Oncotarget.

[62]  Xinheng Li,et al.  LncRNA‐ATB: An indispensable cancer‐related long noncoding RNA , 2017, Cell proliferation.

[63]  B. Gastman,et al.  Tumor-derived exosomes induce CD8+ T cell suppressors , 2017, Journal of Immunotherapy for Cancer.

[64]  R. Blackwell,et al.  The Role of Cancer-Derived Exosomes in Tumorigenicity & Epithelial-to-Mesenchymal Transition , 2017, Cancers.

[65]  A. Llorente,et al.  Current knowledge on exosome biogenesis and release , 2017, Cellular and Molecular Life Sciences.

[66]  Muxing Kang,et al.  Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway , 2017, Scientific Reports.

[67]  R. Hoffman,et al.  Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation , 2017, Oncotarget.

[68]  J. Buchner,et al.  The HSP90 chaperone machinery , 2017, Nature Reviews Molecular Cell Biology.

[69]  M. Zöller,et al.  Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer , 2017, Oncoimmunology.

[70]  Raghu Kalluri,et al.  Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.

[71]  C. di Loreto,et al.  Size-dependent cellular uptake of exosomes. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[72]  V. Thannickal,et al.  Exosomes in immunoregulation of chronic lung diseases , 2017, Allergy.

[73]  Thomas R. Cox,et al.  Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.

[74]  D. Baiwir,et al.  Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes , 2016, Oncotarget.

[75]  Ming Sun,et al.  Long non-coding RNAs in anti-cancer drug resistance , 2016, Oncotarget.

[76]  A. Takaki,et al.  miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. , 2016, Oncology reports.

[77]  M. Brizzi,et al.  Charge-based precipitation of extracellular vesicles , 2016, International journal of molecular medicine.

[78]  Diego Diez,et al.  A novel affinity-based method for the isolation of highly purified extracellular vesicles , 2016, Scientific Reports.

[79]  F. Borràs,et al.  Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles’ characteristics compared to precipitating agents , 2016, Scientific Reports.

[80]  R. Hill,et al.  CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS , 2016, Oncogene.

[81]  M. Zöller,et al.  CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells , 2016, Oncotarget.

[82]  Jin-hai Tang,et al.  Role of long non-coding RNA in tumor drug resistance , 2016, Tumor Biology.

[83]  X. Gallart‐Palau,et al.  Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR , 2016, Molecular Neurodegeneration.

[84]  X. Breakefield,et al.  Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake , 2016, Cellular and Molecular Neurobiology.

[85]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[86]  E. Smit,et al.  Peptide-mediated ‘miniprep’ isolation of extracellular vesicles is suitable for high-throughput proteomics , 2016, EuPA open proteomics.

[87]  D. Santini,et al.  State of the art biological therapies in pancreatic cancer. , 2016, World journal of gastrointestinal oncology.

[88]  Jina Ko,et al.  Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices. , 2016, The Analyst.

[89]  O. Kretz,et al.  Urinary extracellular vesicles for RNA extraction: optimization of a protocol devoid of prokaryote contamination , 2016, Journal of extracellular vesicles.

[90]  A. Carracedo,et al.  Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples , 2016, Journal of extracellular vesicles.

[91]  M. Yáñez-Mó,et al.  Comparative analysis of EV isolation procedures for miRNAs detection in serum samples , 2016, Journal of extracellular vesicles.

[92]  V. Govorun,et al.  Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol , 2015, Scientific Reports.

[93]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[94]  P. Rahman,et al.  Medicinal Plants: Their Use in Anticancer Treatment. , 2015, International journal of pharmaceutical sciences and research.

[95]  Jian Chen,et al.  Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p , 2015, Oncotarget.

[96]  S. Takayama,et al.  High-yield isolation of extracellular vesicles using aqueous two-phase system , 2015, Scientific Reports.

[97]  F. Dieli,et al.  CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA , 2015, Molecular Cancer.

[98]  J. Lynch,et al.  Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function , 2015, PloS one.

[99]  Jiang-xia Zhao,et al.  Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis , 2015, Cell Research.

[100]  X. Breakefield,et al.  Heparin affinity purification of extracellular vesicles , 2015, Scientific Reports.

[101]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[102]  Lei Mu,et al.  Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer , 2015, PloS one.

[103]  Johanna Korvala,et al.  Human Saliva-Derived Exosomes , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[104]  Sha Li,et al.  Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..

[105]  J. Barbuto,et al.  Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets , 2015, Front. Immunol..

[106]  A. Möller,et al.  Optimized exosome isolation protocol for cell culture supernatant and human plasma , 2015, Journal of extracellular vesicles.

[107]  D. Lombardo,et al.  Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1α signaling axis , 2014, Oncoscience.

[108]  George A Calin,et al.  Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.

[109]  Min Zhou,et al.  Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. , 2014, Cellular immunology.

[110]  L. Zitvogel,et al.  Dendritic Cell–Derived Exosomes as Immunotherapies in the Fight against Cancer , 2014, The Journal of Immunology.

[111]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[112]  O. De Wever,et al.  Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. , 2014, Blood.

[113]  C. Guerra,et al.  Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation. , 2014, Cancer research.

[114]  R. Zietse,et al.  Urinary extracellular vesicles and the kidney: biomarkers and beyond. , 2014, American journal of physiology. Renal physiology.

[115]  A. Schroit,et al.  A novel "salting-out" procedure for the isolation of tumor-derived exosomes. , 2014, Journal of immunological methods.

[116]  H. Xia,et al.  Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites , 2014, Journal of clinical and translational hepatology.

[117]  W. Stoorvogel,et al.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting. , 2013, Cold Spring Harbor perspectives in biology.

[118]  M. Mimeault,et al.  Molecular Biomarkers of Cancer Stem/Progenitor Cells Associated with Progression, Metastases, and Treatment Resistance of Aggressive Cancers , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[119]  S. Gallinger,et al.  Diagnosis and management of pancreatic cancer , 2013, Canadian Medical Association Journal.

[120]  Ri-sheng Que,et al.  Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma , 2013, World Journal of Surgical Oncology.

[121]  M. Lotze,et al.  Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer. , 2013, Pancreas.

[122]  W. Ding,et al.  Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.

[123]  M. Ringnér,et al.  Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development , 2013, Proceedings of the National Academy of Sciences.

[124]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[125]  A. Schetter,et al.  Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma , 2013, International journal of cancer.

[126]  Y. Kanai,et al.  Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer , 2013, British Journal of Cancer.

[127]  Z. Werb,et al.  Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.

[128]  C. Trautwein,et al.  Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74 , 2011, Proceedings of the National Academy of Sciences.

[129]  B. Rini,et al.  MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. , 2011, International immunopharmacology.

[130]  S. Natsugoe,et al.  Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. , 2011, The Journal of surgical research.

[131]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[132]  O. De Wever,et al.  Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. , 2010, Journal of the National Cancer Institute.

[133]  K. Preissner,et al.  Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. , 2010, Cancer research.

[134]  B. Chauffert,et al.  Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.

[135]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[136]  M. Ahmadi,et al.  Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. , 2008, Cancer research.

[137]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[138]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[139]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[140]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[141]  William E. Grizzle,et al.  Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function1 , 2006, The Journal of Immunology.

[142]  Li Zhu,et al.  Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells1 , 2005, The Journal of Immunology.

[143]  C. Gross,et al.  Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. , 2005, Cancer research.

[144]  J. Lavail,et al.  The microvesicle as a vehicle for EMMPRIN in tumor–stromal interactions , 2004, Oncogene.

[145]  Y. Iwamoto,et al.  Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. , 1988, Cancer research.

[146]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[147]  Jonathan C. King,et al.  Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes , 2019, Pancreas.

[148]  F. Sánchez‐Madrid,et al.  Post-translational add-ons mark the path in exosomal protein sorting , 2017, Cellular and Molecular Life Sciences.

[149]  T. Whiteside.  Tumor-Derived Exosomes and Their Role in Cancer Progression. , 2016, Advances in clinical chemistry.

[150]  Tao Wang,et al.  Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. , 2015, European urology.

[151]  Richard J Simpson,et al.  A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. , 2015, Methods in molecular biology.

[152]  Thomas Tuschl,et al.  MicroRNAs in human cancer. , 2013, Advances in experimental medicine and biology.